Working to restore movement, independence, and health in people with spinal cord injury.
Location: United States, Indiana, York
Employees: 201-500
Total raised: $40.99M
Founded date: 2014
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 12.01.2023 | Grant | $107.89K | - |
| 20.04.2016 | Series A | $40.89M | - |
Mentions in press and media 10
| Date | Title | Description |
| 23.04.2021 | Swiss-Dutch startup Onward raises €26.5M to enable people with spinal cord injury to move again; here’s how | Eindhoven, Netherlands-based Onward is a medical technology company that creates innovative therapies to restore movement, independence, and health in people with spinal cord injury.Onward raises funding In a recent development, the company... |
| 19.10.2016 | EY-Medtech-Report: Robuste Startups | |
| 14.09.2016 | Top 100 Swiss startups have been revealed | |
| 06.07.2016 | MassChallenge BootCamp: The battle has begun | |
| 20.04.2016 | G-Therapeutics Raises €26M in Series A Financing | G-Therapeutics, a Lausanne, Switzerland-based developer of an implantable neuro stimulator for patients with incomplete spinal cord injury, secured up to €26m in Series A funding. Backers included Gimv, Wellington Partners, LSP and Inkef Ca... |
| 19.04.2016 | G-Therapeutics raises EUR 36 million to develop novel neuro-stimulation therapy for spinal cord injury | G-Therapeutics will use the funds to bring a unique, new therapy for improved rehabilitation of spinal-cord injuries from the lab to patients. In particular, the Company is developing a unique, Implantable Neuro-stimulation System for elect... |
| 19.04.2016 | G-Therapeutics raises EUR 36 million to develop novel neuro-stimulation therapy for spinal cord injury | G-Therapeutics raises EUR 36 million to develop novel neuro-stimulation therapy for spinal cord injury 19.04.2016 00:00, Tina Lohfing linkedIn facebook twitter instagram youtube --> The TOP 100 Swiss Startup 2015 G-Therapeutics has raise... |
| 19.04.2016 | G-Therapeutics raises EUR 36 million | |
| 16.12.2014 | IMD announces Start-up Competition Winners | |
| 05.11.2014 | Asceneuron and G-Therapeutics win international Life Sciences Prize |